Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Burroughs

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Lancet (London, England)|October 2, 2015
Acute-on-chronic liver failureWilliam Bernal, Rajiv Jalan, Alberto Quaglia, et al.
Journal of Hepatology|May 26, 2006
Report of the monothematic EASL conference on liver transplantation for viral hepatitis (Paris, France, January 12-14, 2006)Didier Samuel, Xavier Forns, Marina Berenguer, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 25, 2011
Duct-to-duct biliary reconstruction in orthotopic liver transplantation for primary sclerosing cholangitis: a viable and safe alternativeOsama Damrah, Dinesh Sharma, Andrew Burroughs, et al.
Journal of Hepatology|July 17, 2007
Adrenal insufficiency in liver disease - what is the evidence?James O'Beirne, Michael Holmes, Banwari Agarwal, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 20, 2003
Midterm cost-effectiveness of the liver transplantation program of England and Wales for three disease groupsLouise Longworth, Tracey Young, Martin J Buxton, et al.
Transplantation|July 25, 2006
Severe venoocclusive disease after liver transplantation treated with transjugular intrahepatic portosystemic shuntMarco Senzolo, David Patch, Evangelos Cholongitas, et al.
Current Medical Research and Opinion|June 15, 2007
An economic evaluation of vasoactive agents used in the United Kingdom for acute bleeding oesophageal varices in patients with liver cirrhosisJaroslaw Wechowski, Mark Connolly, Anette Woehl, et al.
Seminars in Liver Disease|February 12, 2013
Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisionsLuigi Bolondi, Andrew Burroughs, Jean-François Dufour, et al.
Journal of Hepatology|June 28, 2012
Evaluation of coagulation abnormalities in acute liver failureBanwari Agarwal, Gavin Wright, Alex Gatt, et al.
The Journal of General Virology|October 15, 2014
Glucocorticosteroids trigger reactivation of human cytomegalovirus from latently infected myeloid cells and increase the risk for HCMV infection in D+R+ liver transplant patientsEllen Van Damme, Sarah Sauviller, Betty Lau, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Lancet (London, England)|October 2, 2015
Acute-on-chronic liver failureWilliam Bernal, Rajiv Jalan, Alberto Quaglia, et al.
Journal of Hepatology|May 26, 2006
Report of the monothematic EASL conference on liver transplantation for viral hepatitis (Paris, France, January 12-14, 2006)Didier Samuel, Xavier Forns, Marina Berenguer, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 25, 2011
Duct-to-duct biliary reconstruction in orthotopic liver transplantation for primary sclerosing cholangitis: a viable and safe alternativeOsama Damrah, Dinesh Sharma, Andrew Burroughs, et al.
Journal of Hepatology|July 17, 2007
Adrenal insufficiency in liver disease - what is the evidence?James O'Beirne, Michael Holmes, Banwari Agarwal, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 20, 2003
Midterm cost-effectiveness of the liver transplantation program of England and Wales for three disease groupsLouise Longworth, Tracey Young, Martin J Buxton, et al.
Transplantation|July 25, 2006
Severe venoocclusive disease after liver transplantation treated with transjugular intrahepatic portosystemic shuntMarco Senzolo, David Patch, Evangelos Cholongitas, et al.
Current Medical Research and Opinion|June 15, 2007
An economic evaluation of vasoactive agents used in the United Kingdom for acute bleeding oesophageal varices in patients with liver cirrhosisJaroslaw Wechowski, Mark Connolly, Anette Woehl, et al.
Seminars in Liver Disease|February 12, 2013
Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisionsLuigi Bolondi, Andrew Burroughs, Jean-François Dufour, et al.
Journal of Hepatology|June 28, 2012
Evaluation of coagulation abnormalities in acute liver failureBanwari Agarwal, Gavin Wright, Alex Gatt, et al.
The Journal of General Virology|October 15, 2014
Glucocorticosteroids trigger reactivation of human cytomegalovirus from latently infected myeloid cells and increase the risk for HCMV infection in D+R+ liver transplant patientsEllen Van Damme, Sarah Sauviller, Betty Lau, et al.
Pageof 5